PortfoliosLab logoPortfoliosLab logo
BF-B vs. MDT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BF-B vs. MDT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Brown-Forman Corporation (BF-B) and Medtronic plc (MDT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BF-B achieves a 3.17% return, which is significantly higher than MDT's -11.80% return. Over the past 10 years, BF-B has underperformed MDT with an annualized return of -2.27%, while MDT has yielded a comparatively higher 2.24% annualized return.


BF-B

1D
3.24%
1M
-0.86%
6M
1.84%
YTD
3.17%
1Y
-5.57%
3Y*
-25.46%
5Y*
-16.48%
10Y*
-2.27%
ALL TIME*
12.70%

MDT

1D
0.11%
1M
5.93%
6M
-12.44%
YTD
-11.80%
1Y
-4.03%
3Y*
1.10%
5Y*
-5.17%
10Y*
2.24%
ALL TIME*
13.23%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BF-B vs. MDT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BF-B
Brown-Forman Corporation
3.17%-29.29%-32.23%-11.91%-8.86%-6.07%18.67%43.78%-10.98%55.01%
MDT
Medtronic plc
-11.80%24.05%0.28%9.58%-22.55%-9.79%5.70%27.34%15.18%15.90%

Correlation

The correlation between BF-B and MDT is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.33

Correlation (3Y)
Calculated over the trailing 3-year period

0.35

Correlation (5Y)
Calculated over the trailing 5-year period

0.39

Correlation (10Y)
Calculated over the trailing 10-year period

0.39

Correlation (All Time)
Calculated using the full available price history since Sep 7, 1984

0.30

Fundamentals

Market Cap

BF-B:

$12.32B

MDT:

$106.62B

EPS

BF-B:

$1.71

MDT:

$3.73

PE Ratio

BF-B:

15.47

MDT:

22.34

PEG Ratio

BF-B:

19.23

MDT:

11.61

PS Ratio

BF-B:

3.19

MDT:

2.95

Total Revenue (TTM)

BF-B:

$3.91B

MDT:

$36.36B

Gross Profit (TTM)

BF-B:

$2.32B

MDT:

$23.64B

EBITDA (TTM)

BF-B:

$1.19B

MDT:

$9.72B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BF-B vs. MDT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BF-B
BF-B Risk / Return Rank: 3737
Overall Rank
BF-B Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
BF-B Sortino Ratio Rank: 3636
Sortino Ratio Rank
BF-B Omega Ratio Rank: 3535
Omega Ratio Rank
BF-B Calmar Ratio Rank: 3838
Calmar Ratio Rank
BF-B Martin Ratio Rank: 3737
Martin Ratio Rank

MDT
MDT Risk / Return Rank: 3636
Overall Rank
MDT Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
MDT Sortino Ratio Rank: 3232
Sortino Ratio Rank
MDT Omega Ratio Rank: 3232
Omega Ratio Rank
MDT Calmar Ratio Rank: 4141
Calmar Ratio Rank
MDT Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BF-B vs. MDT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Brown-Forman Corporation (BF-B) and Medtronic plc (MDT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BF-BMDTDifference
Sharpe ratioReturn per unit of total volatility

+0.03

Sortino ratioReturn per unit of downside risk

+0.16

Omega ratioGain probability vs. loss probability

1.01

0.99

+0.02

Calmar ratioReturn relative to maximum drawdown

-0.22

-0.14

-0.08

Martin ratioReturn relative to average drawdown

-0.47

-0.30

-0.17

BF-B vs. MDT - Sharpe Ratio Comparison

The current BF-B Sharpe Ratio is -0.14, which is comparable to the MDT Sharpe Ratio of -0.17. The chart below compares the historical Sharpe Ratios of BF-B and MDT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BF-B vs. MDT - Drawdown Comparison

The maximum BF-B drawdown since its inception was -68.96%, which is greater than MDT's maximum drawdown of -57.63%. Use the drawdown chart below to compare losses from any high point for BF-B and MDT.


Loading charts...

Drawdown Indicators


BF-BMDTDifference

Max Drawdown

Largest peak-to-trough decline

-68.96%

-57.63%

-11.33%

Max Drawdown (1Y)

Largest decline over 1 year

-25.48%

-28.90%

+3.42%

Max Drawdown (3Y)

Largest decline over 3 years

-65.65%

-28.90%

-36.75%

Max Drawdown (5Y)

Largest decline over 5 years

-68.31%

-45.10%

-23.21%

Max Drawdown (10Y)

Largest decline over 10 years

-68.96%

-45.10%

-23.86%

Current Drawdown

Current decline from peak

-63.73%

-27.93%

-35.80%

Average Drawdown

Average peak-to-trough decline

-11.73%

-16.57%

+4.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.83%

13.24%

-1.41%

Volatility

BF-B vs. MDT - Volatility Comparison

Brown-Forman Corporation (BF-B) has a higher volatility of 11.36% compared to Medtronic plc (MDT) at 10.04%. This indicates that BF-B's price experiences larger fluctuations and is considered to be riskier than MDT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BF-BMDTDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.36%

10.04%

+1.32%

Volatility (6M)

Calculated over the trailing 6-month period

31.77%

18.91%

+12.86%

Volatility (1Y)

Calculated over the trailing 1-year period

38.77%

23.34%

+15.43%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

30.26%

22.34%

+7.92%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.20%

23.45%

+4.75%

Dividends

BF-B vs. MDT - Dividend Comparison

BF-B's dividend yield for the trailing twelve months is around 3.48%, more than MDT's 3.42% yield.


PositionTTM20252024202320222021202020192018201720162015
BF-B
Brown-Forman Corporation
3.48%3.49%2.32%1.46%1.17%2.37%0.88%0.99%3.10%1.09%1.54%1.29%
MDT
Medtronic plc
3.42%2.95%3.49%3.34%3.44%2.39%1.95%1.87%2.15%2.24%2.34%1.88%

Financials

BF-B vs. MDT - Financials Comparison

This section allows you to compare key financial metrics between Brown-Forman Corporation and Medtronic plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B20222023202420252026
1.06B
9.81B
(BF-B) Total Revenue
(MDT) Total Revenue
Values in USD except per share items

BF-B vs. MDT - Profitability Comparison

The chart below illustrates the profitability comparison between Brown-Forman Corporation and Medtronic plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%20222023202420252026
60.6%
75.9%
Portfolio components
BF-B - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Brown-Forman Corporation reported a gross profit of 640.00M and revenue of 1.06B. Therefore, the gross margin over that period was 60.6%.

MDT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Medtronic plc reported a gross profit of 7.44B and revenue of 9.81B. Therefore, the gross margin over that period was 75.9%.

BF-B - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Brown-Forman Corporation reported an operating income of 343.00M and revenue of 1.06B, resulting in an operating margin of 32.5%.

MDT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Medtronic plc reported an operating income of 1.56B and revenue of 9.81B, resulting in an operating margin of 16.0%.

BF-B - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Brown-Forman Corporation reported a net income of 267.00M and revenue of 1.06B, resulting in a net margin of 25.3%.

MDT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Medtronic plc reported a net income of 1.24B and revenue of 9.81B, resulting in a net margin of 12.7%.


Frequently Asked Questions


BF-B and MDT have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BF-B has higher volatility (11.36%) compared to MDT (10.04%). In terms of maximum drawdown, BF-B dropped -68.96% vs MDT's -57.63%.

BF-B currently has the higher Sharpe Ratio (-0.14 vs -0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BF-B and MDT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer